ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 on the Characteristics of Patients With Myelofibrosis on Ruxolitinib for Three or More Years
By
ASCO 2022 Conference Coverage
FEATURING
Lucia Masarova
By
ASCO 2022 Conference Coverage
FEATURING
Lucia Masarova
Login to view comments.
Click here to Login
